Indian biopharma companies and contract drug manufacturers (CDMOs) could see a near-term boost in demand as they help address shortages of key cancer drugs...
Two companies are set to tap the primary market next week, collectively seeking to raise nearly ₹610 crore through their initial public offerings (IPOs).Textile...